Europe Startup Funding Rounds

Startups raising capital across Europe. Compare the businesses, funding stages and investors active in the region.

This page showsRegion: Europe
Rounds
1,513
Jan 1 – Oct 26, 2026
Disclosed funding
$63.6B
1222 disclosed amounts
Median round
$6.9M
Of disclosed amounts
1,513 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
Elax ÉnergieClimate tech · FranceCompany profile

Elax Énergie connects and controls electric water heaters to reduce energy use and shift demand toward periods of abundant electricity.

Elax Énergie connects and controls electric water heaters to reduce energy use and shift demand toward periods of abundant electricity.

€30MUndisclosedClimate techFranceInvestors
Ed.aiEdtech · FranceCompany profile

AI assessment software that helps teachers turn exam papers into editable grading rubrics, review assisted marking and target students’ learning gaps.

AI assessment software that helps teachers turn exam papers into editable grading rubrics, review assisted marking and target students’ learning gaps.

€5MSeedEdtechFranceInvestors
TavionClimate tech · SwedenCompany profile

Tavion develops and operates utility-scale battery parks that provide grid flexibility and help integrate renewable energy.

Tavion develops and operates utility-scale battery parks that provide grid flexibility and help integrate renewable energy.

>SEK 540MEquity round + loan facilityUndisclosedClimate techSwedenInvestors
FuroClimate tech · GermanyCompany profile

Furo provides AI software that plans, controls and optimizes commercial and industrial battery-storage systems, including their participation in energy markets.

Furo provides AI software that plans, controls and optimizes commercial and industrial battery-storage systems, including their participation in energy markets.

$4MFunding roundUndisclosedClimate techGermanyInvestors
Connecta TherapeuticsBiotech · SpainCompany profile

Connecta Therapeutics develops small-molecule treatments for neurological disorders, including CTH120, a clinical-stage candidate for Fragile X syndrome.

Connecta Therapeutics develops small-molecule treatments for neurological disorders, including CTH120, a clinical-stage candidate for Fragile X syndrome.

€3.1MClinical development financingUndisclosedBiotechSpainInvestors
RunPilotClimate tech · United KingdomCompany profile

RunPilot helps infrastructure teams compare route and network options for major energy and linear infrastructure projects before committing to costly designs.

RunPilot helps infrastructure teams compare route and network options for major energy and linear infrastructure projects before committing to costly designs.

£140KEarly-stage fundingUndisclosedClimate techUnited KingdomInvestors
vyznProptech · SwitzerlandCompany profile

AI-assisted building-planning software that evaluates cost, carbon, energy use and occupant comfort from digital building models, giving architects and engineers comparable options early in design.

AI-assisted building-planning software that evaluates cost, carbon, energy use and occupant comfort from digital building models, giving architects and engineers comparable options early in design.

UndisclosedUndisclosed investmentUndisclosedProptechSwitzerlandInvestors
KittsEcommerce · GermanyCompany profile

Kitts is a marketplace where football-shirt fans can buy and sell jerseys and build a public collection of the kits they value.

Kitts is a marketplace where football-shirt fans can buy and sell jerseys and build a public collection of the kits they value.

UndisclosedStrategic investmentUndisclosedEcommerceGermanyInvestors
BiorsafEnterprise software · ItalyCompany profile

Biorsaf provides digital compliance software for food safety and related workplace and water-safety procedures across food businesses and consultants.

Biorsaf provides digital compliance software for food safety and related workplace and water-safety procedures across food businesses and consultants.

€5.2MSeries AEnterprise softwareItalyInvestors
One BiosciencesBiotech · FranceCompany profile

Single-cell tumour profiling for oncology teams and pharma and biotech partners, turning routine biopsy samples into clinical insights for treatment selection and drug development.

Single-cell tumour profiling for oncology teams and pharma and biotech partners, turning routine biopsy samples into clinical insights for treatment selection and drug development.

€3.3Mi-Démo 5 grant (France 2030)UndisclosedBiotechFranceInvestors

Active investors in this selection

All investors →

Ranked by rounds participated in · From Jan 1, 2026

  1. 1
    High-Tech Gründerfonds

    Rabot Energy, TODAY, Finches

    39rounds
    4led
  2. 2
    Antler

    Jenz, Affinity Labs, CodeWall

    26rounds
    0led
  3. 3
    Y Combinator (YC)

    HyLight, Sensible Biotechnologies, Revnu

    22rounds
    1led
  4. 4
    General Catalyst

    Legora, Complir, Integral

    21rounds
    1led
  5. 5
    Index Ventures

    Opply, Duvo, Spiko

    21rounds
    2led

Latest digests

Archive →

Explore published rounds while the next edition is being prepared.

Browse rounds by topic